Thursday, June 22, 2023 11:47:28 PM
Market Cap 16.367 Million Shares
Outstanding 16.367 Billion Avg 30-day
Volume 12.293 Million
P/E Ratio 0.0 Dividend Yield 0.0
EPS -0.4
Price to Revenue 0.0 Debt to
Equity -0.187
EBITDA -23.892 Million
Price to Book Value 0.0 Operating Margin 0.0
Enterprise Value 27.797 Million
Current Ratio 0.194 EPS Growth -5.667 Quick Ratio 0.116
1 Yr BETA 0.5417 52-week High/Low 0.0 / Profit Margin 0.0
Operating Cash Flow Growth -208.0228
Altman Z-Score -416.4344
Free Cash Flow to Firm -18.577 Million
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM